Product: Ranitidine Tablets, USP 150 mg, a.) 24 count bottles (NDC 63868-480-24), b.) 50-count bottles (NDC 63868-480-50) (CDMA) OTC
Reason for recall: CGMP Deviations: Presence of NDMA impurity detected in product.
Recall initiated: 20191001
Status: Completed
Classification: Class II
Recall type: Voluntary: Firm initiated